Effect of axillary hair epilation therapy using a Diode laser with a combined wavelength of 810, 940, and 1,060 nanometers in static mode compared to dynamic mode on sweat production

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20231110004

Enrollment

Registered

2023-11-10

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillary hyperhidrosis in volunteers with unwanted axillary hairs after hair epilation therapy using a Diode laser Hair removal laser, Axillary hair, Hyperhidrosis

Interventions

Using combined 810, 940, 1060 nm Diode laser with traditional/static mode at left axilla , and combined 810, 940, 1060 nm Diode laser with continuous/dynamic mode at right axilla in one individual.,U

Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patient with unwanted axillary hairs who want to treat with hair removal laser, 2. Age between 18-45 years old, 3. Willing to participate the study, 4. Able to come follow the appointment

Exclusion criteria

Exclusion criteria: 1. Presence of focal, visible sweating for at least 6 months without any obvious cause in addition to the presence of at least 2 of the following characteristics: Bilateral and relatively symmetrical (Affects daily activities, More than one time per week, Younger than 25 years old at the beginning of hyperhidrosis, Positive family history, Absence of night sweats or sweating during sleeping periods), 2. Comorbidities which can cause secondary hyperhidrosis (Heart diseases, Diabetes, Thyroid diseases, Pheochromocytoma), 3. Currently has any kind of malignant cancers, 4. Medications which can cause secondary hyperhidrosis within 15 days, 5. Have any history of undergoing axillary gland excision, liposuction, sympathectomy and subcutaneous curettage, 6. History of currently using Aluminium Chloride solution for hyperhidrosis, 7. History of undergoing any laser at axilla within 6 months, 8. History of Botulinum toxin A injection or Iontophoresis or Microwave therapy at axilla within 12 months, 9. Pregnancy, 10. Menopause, 11. Heat-stimulated diseases or Disease with Koebners phenomenon eg. Psoriasis, Lichen planus, Vitiligo, Halo nevus, 12. Any skin diseases in axillary area eg. eccrine nevus, and infection at axillary area

Design outcomes

Primary

Measure	Time frame
Sweat production Day 0, week 4, 8, 12, 18, 24 Gravimetry, Iodine starch test with SIVS score, and HDSS score	—

Secondary

Measure	Time frame
Malodor Day 0, week 4, 8, 12, 18, 24 Modified axillary malodor score,Adverse effects Day 0, week 4, 8, 12, 18, 24 Observation,Patient's satisfaction week 24 10-point scale	—

Countries

Thailand

Contacts

Public ContactChanawee Dopphoopha

Department of Dermatology, Faculty of Medicine, Srinakharinwirot University

chanawee.dop@g.swu.ac.th66819836288

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026